The workshop will showcase cutting-edge advances in cancer research, exploring innovative approaches in childhood and metastatic cancers, tumor metabolism, therapy resistance, and the challenges of precision medicine. Participants will learn how science is tackling cancer from multiple angles, combining fundamental discoveries with translational applications.
We look forward to welcoming you to this insightful event!
Presentation
ADAPTMET’s mission is to train and empower the next generation of cancer researchers through its trans-disciplinary program that combines scientific excellence with professional development, equipping doctoral candidates with the skills and knowledge to innovate in cancer therapy. This workshop offers a unique chance to experience ADAPTMET’s approach firsthand and connect with emerging leaders in metastasis research.
Adaptmet Workshop: Frontiers in Metastasis Research
DATE: Friday 14 November 2025
TIME: 9:00 - 12:30
PLACE: Antoni Caparrós Auditorium, PCB Campus, Barcelona
The event is free and open to all members of the PCB community. External attendees are welcome to join by registering at least 24 hours in advance via this registration link.
For any enquiries, contact adaptmet@irbbarcelona.org
Programme
Adaptmet Workshop: Frontiers in Metastasis Research
9:00 – 9:05 Roger Gomis (IRB Barcelona): Welcome
9:05 – 9:30 Alexandra Avgustinova (IRB Barcelona): The Winding Road to Precision Medicine in Childhood Cancer: Chasing a Moving Target
9:30 – 9:55 Kristian Pietras (Lund University): Signaling at the Crossroads between Tumor Angiogenesis and Immunity
9:55 – 10:20 Aura Muntasell (UAB/HMRIB): Subverting TGF-β–Mediated Suppression to Enhance NK Cell Anti-Tumor Function
10:20 – 11:00 Networking coffee break
11:00 – 11:25 Victoria Sanz-Moreno (ICR): Biomechanical Hallmarks and Vulnerabilities of Metastatic and Therapy Resistant Cancer Cells
11:25 – 11:50 Sara Sdelci (CRG): Nuclear Metabolic Control in Cancer Treatment
11:50 – 12:15 Eduard Batlle (IRB Barcelona): Plasticity and Therapy Resistance in Metastatic Colorectal Cancer
12:15 – 12:30 Roger Gomis (IRB Barcelona): Final Conclusions
Poster
